Related Experiment Video
Updated: Jun 10, 2026
09:36
Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats
Published on: October 16, 2010
Columnar cell lesions and subsequent breast cancer risk: a nested case-control study
Sarah A Aroner1, Laura C Collins, Stuart J Schnitt
1Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA. sarah.aroner@channing.harvard.edu
Breast Cancer Research : BCR
|August 10, 2010
Summary
Columnar cell lesions (CCL) in benign breast biopsies may indicate higher breast cancer risk. However, this risk is linked to other proliferative changes, not CCL alone.
Area of Science:
- Oncology
- Pathology
- Epidemiology
Background:
- Columnar cell lesions (CCL) are suspected precursors in low-grade breast neoplasia.
- The association between CCL in benign breast biopsies and subsequent breast cancer risk requires further clarification.
Purpose of the Study:
- To investigate the relationship between the presence of CCL in benign breast biopsies and the risk of developing breast cancer.
Main Methods:
- A nested case-control study was conducted using data from the Nurses' Health Studies.
- Benign breast biopsy slides were reviewed to identify CCL.
- Logistic regression analysis was employed to assess breast cancer risk associated with CCL.
Main Results:
- Women with CCL showed an initial increased risk of breast cancer (OR = 1.44).
- This association became non-significant after adjusting for benign breast disease (BBD) histology (OR = 1.20).
- No significant interaction was found between CCL presence and BBD category regarding breast cancer risk.
Conclusions:
- CCL may serve as a marker for breast cancer risk in women with BBD.
- CCL do not appear to independently elevate breast cancer risk beyond concurrent proliferative changes.
